A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes

Acta Diabetologica

Volumn 51, Issue 2, 2014, Pages 205-210

  Mameli, Chiara ^a   Scaramuzza, Andrea E ^a   Ho, Josephine ^b   Cardona Hernandez, Roque ^c   Suarez Ortega, Larisa ^c   Zuccotti, Gian Vincenzo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CALGARY   (Canada)

^c HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

Adolescents; Children; Continuous subcutaneous insulin infusion; Insulin pump therapy; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CANADA; CHILD; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; ITALY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SPAIN; BLOOD; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; INSULIN INFUSION; METABOLISM; MULTICENTER STUDY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; BODY MASS INDEX; CANADA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN INFUSION SYSTEMS; ITALY; MALE; RETROSPECTIVE STUDIES; SPAIN; YOUNG ADULT;

EID: 84898403109     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0481-y     Document Type: Article

References (27)

1. The Diabetes Control Complication Trial (DCCT) Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 329:977-986
2. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853
3. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2652
4. Monami M, Lamanna C, Marchionni N, Mannucci E (2010) Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. Acta Diabetol 47(Suppl 1):77-81
5. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J (2010) Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 20(1):CD005103
6. Weinzimer SA, Ternand C, Howard C, Chang CT, Becker DJ, Laffel LM, Insulin Aspart Pediatric Pump Study Group (2008) A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes. Diabetes Care 31:210-215
7. Ahern JA, Boland EA, Doane R, Ahern JJ, Rose P, Vincent M, Tamborlane WV (2002) Insulin pump therapy in pediatrics: a safe alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes 3:10-15
8. Yeh HC, Brown TT, Maruthur N et al (2012) Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med 157:336-347
9. Sulli N, Shashaj B (2006) Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up. Diabet Med 23:900-906
10. Scrimgeour L, Cobry E, McFann BS, Burdick P, Weimer C, Slover R, Chase HP (2007) Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes. Diabetes Technol Ther 9:421-428
11. Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M (2010) Predictors of glycemic control in patients with type 1 diabetes commencing continuous subcutaneous insulin infusion therapy. Diabet Med 27:339-347
12. Hughes CR, McDowell N, Cody D, Costigan C (2012) Sustained benefits of continuous subcutaneous insulin infusion. Arch Dis Child 97:245-247
13. Batajoo RJ, Messina CR, Wilson TA (2012) Long-term efficacy of insulin pump therapy in children with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol 4:127-131
14. Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT, Tamborlane WV (2004) Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up study. Pediatrics 114:1601-1605
15. Walsh J, Roberts R, Bailey T (2011) Guidelines for optimal bolus calculator settings in adults. J Diabetes Sci Technol 5:129-135
16. O'Connell MA, Donath S, Cameron FJ (2011) Poor adherence to integral daily tasks limits the efficacy of CSII in youth. Pediatr Diabetes 12:556-559
17. Cukierman-Yaffe T, Konvalina N, Cohen O (2011) Key elements for successful intensive insulin pump therapy in individuals with type 1 diabetes. Diabetes Res Clin Pract 92:69-73
18. Scaramuzza AE, Iafusco D, Santoro L, Bosetti A, De Palma A, Spiri D, Mameli C, Zuccotti GV (2010) Timing of bolus in children with type 1 diabetes using continuous subcutaneous insulin infusion (TiBoDi Study). Diabetes Technol Ther 12:149-152
19. Luijf YM, van Bon AC, Hoekstra JB, DeVries JH (2010) Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes. Diabetes Care 33:2152-2155
20. De Palma A, Giani E, Iafusco D, Bosetti A, Macedoni M, Gazzarri A, Spiri D, Scaramuzza AE, Zuccotti GV (2011) Lowering postprandial glycemia in children with type 1 diabetes after Italian pizza 'margherita' (TyBoDi2 Study). Diabetes Technol Therap 13:483-487
21. Cherubini V, Gesuita R, Bonfanti R, Franzese A, Frongia AP, Iafusco D, Iannilli A, Lombardo F, Rabbone I, Sabbion A, Salvatoni A, Scaramuzza A, Schiaffini R, Sulli N, Toni S, Tumini S, Mosca A, Carle F; VIPKIDS Study Group. (2013) Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. The VIPKIDS study. Acta Diabetol [Epub ahead of print]
22. Maniatis AK, Toig SR, Kingensmith GJ, Fay-Itzkowitz E, Chase HP (2001) Life with continuous subcutaneous insulin infusion (CSII) therapy: child and parental perspectives and predictors of metabolic control. Pediatr Diabetes 2:51-57
23. Ahern JA, Boland EA, Doane R, Ahern JJ, Vincent M, Tamborlane WV (2002) Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes 3:10-15
24. Plotnick LP, Clark LM, Brancati F, Erlinger T (2003) Diabetes Care 26:1142-1146
25. Willi SM, Planton J, Egede L, Schwarz S (2003) Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr 143:796-801
26. De Wit M, Snoek FJ (2011) Depressive symptoms and unmet psychological needs of Dutch youth with type 1 diabetes: results of a web-survey. Pediatr Diabetes 12(3 pt 1):172-176
27. de Vries L, Grushka Y, Lebenthal Y, Shalitin S, Phillip M (2011) Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes. Pediatr Diabetes 12(5):506-512